Home Biosimilar Antibodies Endocrinology & Hormones GPR antibody Petosemtamab (Anti-GPR49 / LGR5) For research use only.
Not for use in humans.

Petosemtamab (Anti-GPR49 / LGR5)

Synonyms:  MCLA 158

Petosemtamab (Anti-GPR49 / LGR5) is an monoclonal antibody that targets GPR49/LGR5. It blocks the appearance of metastases and slows the growth of primary tumors in experimental cancer models. Petosemtamab can be used in the research of solid tumors, such as head and neck squamous cell carcinoma (HNSCC), metastatic colorectal cancer (CRC). MW: 145.5 KD.

Petosemtamab (Anti-GPR49 / LGR5)

Purity & Quality Control

≥99

Choose Selective GPR Inhibitors

Biological Activity

Description Petosemtamab (Anti-GPR49 / LGR5) is an monoclonal antibody that targets GPR49/LGR5. It blocks the appearance of metastases and slows the growth of primary tumors in experimental cancer models. Petosemtamab can be used in the research of solid tumors, such as head and neck squamous cell carcinoma (HNSCC), metastatic colorectal cancer (CRC). MW: 145.5 KD.

Product Details

CAS No. 2213450-26-9
Molecular Weight 145.5 kDa
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Petosemtamab (Anti-GPR49 / LGR5) | Petosemtamab (Anti-GPR49 / LGR5) supplier | purchase Petosemtamab (Anti-GPR49 / LGR5) | Petosemtamab (Anti-GPR49 / LGR5) cost | Petosemtamab (Anti-GPR49 / LGR5) manufacturer | order Petosemtamab (Anti-GPR49 / LGR5) | Petosemtamab (Anti-GPR49 / LGR5) distributor